Co-Diagnostics (CODX)
5.05
-0.58 (10.30%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Co-Diagnostics, Inc. Filed by: JANE STREET GROUP, LLC
June 3, 2026 4:22 PM - SEC Filing
Co-Diagnostics advances Ebola PCR test development with CoSara venture
June 2, 2026 9:01 AM - StreetInsider
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 2, 2026 9:00 AM - PR NewsWire
Form EFFECT Co-Diagnostics, Inc.
June 1, 2026 6:08 AM - SEC Filing
Form S-3 Co-Diagnostics, Inc.
May 28, 2026 5:12 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Egan Dwight H
May 27, 2026 4:05 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Brown Brian Lee
May 27, 2026 4:04 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Abbott Richard David
May 27, 2026 4:04 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: Murphy Edward L.
May 27, 2026 4:03 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: SERBIN RICHARD S
May 27, 2026 4:03 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 27 Filed by: Durenard Eugene
May 27, 2026 4:03 PM - SEC Filing
Form 4 Co-Diagnostics, Inc. For: May 23 Filed by: NELSON JAMES B
May 27, 2026 4:02 PM - SEC Filing
Co-Diagnostics develops ebola test strategy with CoSara joint venture
May 26, 2026 9:00 AM - StreetInsider
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
May 26, 2026 9:00 AM - PR NewsWire
Form 8-K Co-Diagnostics, Inc. For: May 19
May 21, 2026 8:02 AM - SEC Filing
Co-Diagnostics secures $3 million private placement
May 19, 2026 10:55 PM - StreetInsider
Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
May 19, 2026 10:55 PM - PR NewsWire
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
May 19, 2026 9:01 AM - PR NewsWire
Form EFFECT Co-Diagnostics, Inc.
May 18, 2026 6:04 AM - SEC Filing
Co-Diagnostics (CODX) Misses Q1 EPS by 406c
May 14, 2026 4:42 PM - StreetInsider
Form 10-Q Co-Diagnostics, Inc. For: Mar 31
May 14, 2026 4:11 PM - SEC Filing
Form 8-K Co-Diagnostics, Inc. For: May 14
May 14, 2026 4:06 PM - SEC Filing
Co-Diagnostics Reports First Quarter 2026 Financial Results
May 14, 2026 4:01 PM - PR NewsWire
Co-Diagnostics (CODX) files $150M mixed shelf
May 12, 2026 4:34 PM - StreetInsider
Form S-3 Co-Diagnostics, Inc.
May 12, 2026 4:32 PM - SEC Filing
Co-Diagnostics joint venture secures saudi arabia manufacturing lease
May 8, 2026 9:00 AM - StreetInsider
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
May 8, 2026 9:00 AM - PR NewsWire
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
April 30, 2026 9:01 AM - PR NewsWire
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
April 16, 2026 9:04 AM - PR NewsWire
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
April 14, 2026 9:02 AM - PR NewsWire
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
April 9, 2026 9:01 AM - PR NewsWire
Co-Diagnostics joint venture secures Saudi Arabia manufacturing site
April 2, 2026 9:02 AM - StreetInsider
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
April 2, 2026 9:02 AM - PR NewsWire
Form 10-K Co-Diagnostics, Inc. For: Dec 31
March 31, 2026 4:11 PM - SEC Filing
Form 8-K Co-Diagnostics, Inc. For: Mar 31
March 31, 2026 4:07 PM - SEC Filing
Co-Diagnostics Reports Full Year 2025 Financial Results
March 31, 2026 4:01 PM - PR NewsWire
Co-Diagnostics ships TB testing materials to India for clinical studies
March 25, 2026 8:02 AM - StreetInsider
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
March 25, 2026 8:00 AM - PR NewsWire
Co-Diagnostics expands South Asia territory to include four new markets
March 20, 2026 8:01 AM - StreetInsider
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026 8:01 AM - PR NewsWire
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
March 17, 2026 9:01 AM - PR NewsWire
Co-Diagnostics to Present at Medical Korea 2026
March 16, 2026 9:00 AM - PR NewsWire
Co-Diagnostics receives Japanese patent for PCR platform technology
March 12, 2026 9:02 AM - StreetInsider
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 12, 2026 9:02 AM - PR NewsWire
Form 8-K Co-Diagnostics, Inc. For: Mar 09
March 10, 2026 9:26 AM - SEC Filing
Co-Diagnostics regains NASDAQ compliance, shares to resume trading
March 10, 2026 9:03 AM - StreetInsider
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
March 10, 2026 9:02 AM - PR NewsWire
Full Article List
